Skip to main content
HCPCS J2002 · Level II · Part B drug

HCPCS J2002: Injection, lidocaine hcl in 5% dextrose, 1 mg

Reviewed by QuickIntell RCM Editorial Team · Last reviewed

Data effective
Data currency: ASP payment limits October 2026 (effective October 1, 2026); MUE and NCCI edits 2026 Q4 (effective October 1, 2026); OPPS Addendum B July 2026 (effective July 1, 2026). Next CMS release: January 1, 2027 (ASP, MUE, NCCI and OPPS quarterly updates).

Key facts for J2002

Billing unit
1 MG
Inj, lidocaine in d5w, 1 mg
ASP payment limit
$0.003
October 2026; +0.0% vs July 2026
Practitioner MUE
2000
MAI 3
OPPS status
SI N
NCCI exposure
7 col-2 pairs
100% allow a modifier
Coverage articles
0
none list this code

TL;DR

HCPCS J2002 is the Level II code for Injection, lidocaine hcl in 5% dextrose, 1 mg, billed per 1 MG. The Medicare Part B ASP payment limit for October 2026 is $0.003 per billing unit, up 0.0% from July 2026. The practitioner MUE allows up to 2000 units per date of service (MAI 3). Under OPPS it carries status indicator N. With a 1 mg billing unit, a single administration can be hundreds of units; the unit count on the claim must equal the milligrams given, and rounding rules for partial units follow the contractor's guidance. The ASP crosswalk maps 9 NDCs to it, sold as Lidocaine In D5W, Lidocaine in D5W, Lidocaine HCl by B. Braun Medical Inc., Baxter Healthcare Corporation, A-S Medication Solutions. It is the bundled column-2 code in 7 NCCI pairs, most often with 15011, 15013, 15015. No current Billing and Coding Article lists J2002, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J2002 at $0.003 per 1 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.003 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J2002
QuarterPayment limitPerCoinsurance
October 2026$0.0031 MG20%
July 2026$0.0031 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 9 NDCs from 4 labelers to J2002. Report the NDC in the claim's drug segment and bill the number of J2002 units that equals the quantity administered divided by 1 MG; the last column gives units per full package.

NDCs that crosswalk to J2002
NDCDrug nameLabelerPackage sizeBilling units / package
00264-9594-10Lidocaine In D5WB. Braun Medical Inc.500 × 2448000
00264-9594-20Lidocaine In D5WB. Braun Medical Inc.250 × 2424000
00264-9598-20Lidocaine In D5WB. Braun Medical Inc.250 × 2448000
00338-0409-03Lidocaine In D5WBaxter Healthcare Corporation500 × 1836000
00338-0411-02Lidocaine In D5WBaxter Healthcare Corporation250 × 12000
50090-4555-00Lidocaine in D5WA-S Medication Solutions250 × 12000
50090-4559-00Lidocaine in D5WA-S Medication Solutions500 × 12000
51662-1302-01Lidocaine in D5WHF Acquisition Co. LLC, DBA HealthFirst500 × 12000
51662-1600-03Lidocaine HClHF Acquisition Co. LLC, DBA HealthFirst50 × 256250

Medically Unlikely Edits (MUE)

CMS publishes 2 MUE values for J2002. For practitioners the limit is 2000 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J2002 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services20003 Date of Service Edit: ClinicalClinical: Data
Facility outpatient hospital40003 Date of Service Edit: ClinicalPrescribing Information

NCCI edits and add-on relationships

In the practitioner PTP file v323r0 (effective October 1, 2026), J2002 is the column-2 code in 7 active pairs, 100% of which allow a modifier (indicator 1), and the column-1 code in 0. 0 historical pairs have been deleted over time. CMS's most frequent rationale: Misuse of Column Two code with Column One code.

When billed with these column-1 codes, J2002 is the bundled component unless the pair allows a modifier and the documentation supports a distinct service.

Column-1 codes most often paired with J2002
Column-1 codePairs
15011 (CPT; descriptor licensed by AMA)1
15013 (CPT; descriptor licensed by AMA)1
15015 (CPT; descriptor licensed by AMA)1
15017 (CPT; descriptor licensed by AMA)1
51721 (CPT; descriptor licensed by AMA)1
53865 (CPT; descriptor licensed by AMA)1
53866 (CPT; descriptor licensed by AMA)1

J2002 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J2002 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the July 2026 OPPS Addendum B, J2002 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Common denials for J2002 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

How QuickIntell checks J2002 before the claim leaves

QuickCode validates the NDC-to-unit conversion against the current ASP crosswalk, checks units against every published MUE setting and flags PTP and add-on conflicts on the same claim. QuickRCM routes CARC 16, 151 and 50 denials on drug lines with the matching coverage article attached so the appeal starts with evidence.

Frequently asked questions — HCPCS J2002

What does HCPCS code J2002 describe?

J2002 is defined by CMS as "Injection, lidocaine hcl in 5% dextrose, 1 mg". Each billing unit represents 1 MG, so the units reported on the claim must equal the dose administered divided by that unit.

What is the Medicare reimbursement for J2002 in October 2026?

The ASP-based payment limit is $0.003 per 1 MG, with 20% beneficiary coinsurance. Medicare Administrative Contractors apply this limit; commercial payers use their own fee schedules. The July 2026 limit was $0.003.

How many units of J2002 can be billed per day?

The practitioner Medically Unlikely Edit is 2000 units per date of service with adjudication indicator 3 (3 Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.

Which NDCs map to J2002?

The October 2026 ASP crosswalk lists 9 NDCs from 4 labelers: Lidocaine In D5W (B. Braun Medical Inc.); Lidocaine In D5W (Baxter Healthcare Corporation); Lidocaine in D5W (A-S Medication Solutions); Lidocaine in D5W (HF Acquisition Co. LLC, DBA HealthFirst). For example NDC 00264-9594-10 is a 500 package equal to 48000 billing units. The crosswalk's billing-units-per-package figure converts each package into J2002 units.

Does J2002 have NCCI bundling edits?

In the v323r0 practitioner PTP file, J2002 appears as the column-2 (bundled) code in 7 active pairs and as the column-1 code in 0. 100% of the column-2 pairs allow a modifier (indicator 1). The most frequent column-1 partners are 15011, 15013, 15015, 15017, 51721, and CMS's leading rationale is "Misuse of Column Two code with Column One code".

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-01. Verify against the primary file before billing or contracting decisions.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B and the Medicare Coverage Database. Payment limits are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.